REG - Greencare Capital - Directorate Changes

Wam CapitalAnnouncement

28/04/2022 08:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220428:nRSb6744Ja&default-theme=true

RNS Number : 6744J  Greencare Capital PLC  28 April 2022

 

 

28 April 2022

 

Greencare Capital PLC

("Greencare" or the "Company")

Directorate Changes

 

Greencare (AQSE: GRE), the investment company focused on investing in
medicinal cannabis, CBD and related wellness areas, announces the following
Board changes with immediate effect.

 

Mr Dominic White joins the Board as Non-Executive Chairman and Mr Martin
Walton has been appointed an independent Non-executive Director. Richard
Tonthat  is stepping down as Chief Executive Officer in order to pursue other
business interests. Mr Guy Winterflood, who has been a Non-executive Director
since the Company's flotation, is also stepping down from the Board in order
to devote more time to his Chairmanship of Hempflax BV of The Netherlands, one
of Europe's largest growers of Hemp for industrial use.

 

Dominic White has over 25 years' experience in the investment sector and has
managed more than £3 billion of assets in the UK and Europe across multiple
sectors, in public companies, funds, joint-ventures and regulated activities.
He has held Board Level executive and non-executive positions in numerous
public companies and international investment institutions such as Henderson
Global Investors. Mr White is a member of the Institute of Chartered Financial
Analysts.

 

Mr White is Executive Chairman of AQSE quoted Eight Capital Partners plc and
is on the Board of a number of other private companies.

 

Martin Walton has many years' experience at Board level of companies within
the life sciences, biotech and medtech sectors/industries and within
investment and commercial banking. He is currently a Non-executive Director of
AIM listed Reneuron Group plc, a UK-based leader in Stem Cell and Exosomes
Technologies and is Chairman and CEO of Bradshaw Consulting Limited, a
strategic advisory group assisting companies and shareholders in creating,
generating and realising value from investments in life sciences and tech
sectors. He was previously at Excalibur Group Fund Management, was a
co-founder of Arix Bioscience plc and Arthurian Life Sciences Limited and has
held senior positions at Standard Bank and Toronto-Dominion Bank.

 

On joining the Board as Non-Executive Chairman, Mr White commented:

"On behalf of the Board, I would like to thank both Richard and Guy for their
commitment and service to the Company over the past two years, and wish them
well in their future endeavours. I also welcome Martin to the Board where his
combined life sciences and corporate finance and investment banking experience
will be of great value as the Company moves forward.

 

"I am pleased to have the opportunity to join Greencare at this time.   The
CBD and cannabis sector continues to develop, and, as it matures, we expect
there to be opportunities, consolidation and rationalisation. Greencare will
continue to actively pursue acquisition and investment opportunities of
varying size in the cannabis and wellbeing space as well as taking a broader
view of opportunities within our stated investing strategy

 

 

 

Enquiries:

 

 Greencare Capital plc          C/O Wakbrook PR Limited

 Dominic White                  +44 (0)20 7933 8780

 Cairn Financial Advisers LLP   +44 (0)20 7213 0880

 AQSE Corporate Adviser

 Jo Turner / James Lewis

 Walbrook PR Limited            +44 (0)20 7933 8780

 Paul Vann/Nick Rome            +44 (0)7768 807631

                                greencarecapital@walbrookpr.com

 

 

The following information is disclosed pursuant to Rule 4.9 of the AQSE Growth
Market Access Rulebook.

 

Dominic Andrew White (aged 50) holds or has held the following directorships
or partnerships in the past five years:

 

 Current Directorships or Partnerships  Previous Directorships or Partnerships
 Dharma Dragon Ltd                      12250088 Limited (previously Supply@Me Capital Limited)
 Eight Capital Partners PLC             Drumz PLC
 E-Ledger Capital Solutions Ltd         eMed Pharma Group Limited
 IWEP Ltd                               Maximum Return System Ltd
 K&C (Coleherne) Limited                Ovio Wellness Limited
 K&C (Newbury) Limited                  Supply@Me Capital PLC
 K&C (Osprey) Limited                   Windustries Ltd
 KCR (Kite) Limited                     Zamaz PLC
 KCR (Southampton) Limited
 KCR Residential Reit PLC
 Maximum Return System Ltd
 Maximum Return Systems Group LLP
 White Amba Ltd

 

Mr White holds 8,000,000 Ordinary shares in the Company through a holding
entity, representing 54.1% of its issued share capital. Eight Capital Partners
plc, a company of which Mr White is a director and significant shareholder,
holds 2,560,000 ordinary shares in the Company representing 17.3% of its
issued share capital.

 

Mr White was a director of Ovio Wellness Limited, a health drinks company,
which was dissolved in February 2019 following the company being placed into
creditors voluntary liquidation in August 2017.

 

Mr Martin Charles Walton (aged 58 ) holds or has held the following
directorships or partnerships in the past five years:

 

 Current Directorships or Partnerships  Previous Directorships or Partnerships
 ReNeuron Group plc                     Anontec Limited
 Bradshaw Consulting Ltd                Arix Capital Management Limited
 Excalibur Medicines Ltd                Arthurian Life Sciences Gp Limited
 Igraine plc                            Arthurian Life Sciences Spv Gp Limited
 Interrad Medical Inc                   Excalibur Fund Managers Limited
                                        Iatros Capital Limited
                                        Iota Sciences Limited
                                        PZT Limited
                                        Simbec-Orion Group Limited

 

 

Mr Walton does not hold any shares in the Company.

 

There is no further information to be disclosed pursuant to Rule 4.9 of the
AQSE Growth Market Rulebook.

 

Notes:

Greencare Capital plc is an investment company quoted on the Aquis Stock
Exchange Growth Market ("AQSE"). The Company was incorporated on 1 October
2019 and its shares were admitted to trading on 30 December 2019.

 

The Company's investment strategy is to focus on investments in cannabis
sectors within countries predominantly in Europe whose jurisdictions have
well-developed and reputable laws and regulations for its production, research
and distribution; together with the CBD and hemp sectors.

 

The Company will invest directly or indirectly in public or private companies,
in supply and distribution chains, or other business associated with the
cannabis sector. Investments may take the form of debt or equity and it is
expected that such investments will ordinarily seek capital growth in the
medium term in preference to income.

 

The Company will not invest in the recreational cannabis sector, or in
entities or activities supported by it, nor any other related activities which
would be deemed illegal under UK legislation.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NEXKZGZDKRFGZZG